Revenue growth has stalled at 0.0% in 2026Q1, while gross margins have compressed from 34.1% in 2024Q2 to 31.7% due to unfavorable product mix shifts.
| Sales/Revenue | 6.55B | 6.55B | 6.78B | 6.97B | 7.51B | 7.39B | 6.39B | 6.04B | 5.86B | 1.25B | 691.3M |
| Revenue Growth % | -1.99% | -3.41% | -2.64% | -7.26% | 1.71% | 15.52% | 5.85% | 3% | 370.12% | 80.44% | - |
| Cost of Goods Sold | 4.45B | 4.41B | 4.5B | 4.6B | 4.91B | 4.88B | 4.31B | 4.12B | 4.04B | 814.6M | 371.6M |
| COGS % of Revenue | - | 67.35% | 66.4% | 66.07% | 65.35% | 66.12% | 67.46% | 68.2% | 68.97% | 65.3% | 53.75% |
| Gross Profit | 2.11B | 2.14B | 2.28B | 2.36B | 2.6B | 2.5B | 2.08B | 1.92B | 1.82B | 432.8M | 319.7M |
| Gross Margin % | 32.13% | 32.65% | 33.6% | 33.93% | 34.65% | 33.88% | 32.54% | 31.8% | 31.03% | 34.7% | 46.25% |
| Gross Profit Growth % | - | -6.14% | -3.57% | -9.18% | 4% | 20.29% | 8.32% | 5.54% | 320.47% | 35.38% | - |
| Operating Expenses | 2.38B | 2.39B | 1.19B | 1.67B | 1.47B | 1.53B | 1.37B | 1.37B | 1.41B | 643.2M | 309.8M |
| OpEx % of Revenue | - | 36.41% | 17.61% | 23.93% | 19.6% | 20.72% | 21.49% | 22.66% | 23.98% | 51.56% | 44.81% |
| Selling, General & Admin | 1.21B | 1.6B | 1.64B | 1.51B | 1.47B | 1.53B | 1.37B | 1.37B | 1.41B | 643.2M | 309.8M |
| SG&A % of Revenue | - | 24.35% | 24.19% | 21.62% | 19.6% | 20.72% | 21.49% | 22.66% | 23.98% | 51.56% | 44.81% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19.1M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | 2.76% |
| Other Operating Expenses | 3M | 790.1M | -446.6M | 160.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -278.6M | -246.2M | 1.08B | 696.4M | 1.13B | 972.2M | 706.8M | 551.8M | 413.5M | -210.4M | 9.9M |
| Operating Margin % | -4.25% | -3.76% | 15.99% | 10% | 15.04% | 13.16% | 11.05% | 9.14% | 7.05% | -16.87% | 1.43% |
| Operating Income Growth % | - | -122.7% | 55.77% | -38.38% | 16.25% | 37.55% | 28.09% | 33.45% | 296.53% | -2225.25% | - |
| EBITDA | 136.9M | 164M | 1.49B | 1.1B | 1.54B | 1.35B | 1.1B | 950.7M | 818.1M | -111.2M | 70.2M |
| EBITDA Margin % | 2.09% | 2.5% | 21.97% | 15.77% | 20.44% | 18.3% | 17.24% | 15.74% | 13.95% | -8.91% | 10.15% |
| EBITDA Growth % | -90.82% | -89% | 35.64% | -28.46% | 13.64% | 22.61% | 15.94% | 16.21% | 835.7% | -258.4% | - |
| D&A (Non-Cash Add-back) | 415.5M | 410.2M | 405.5M | 402.3M | 405.5M | 379.2M | 395.4M | 398.9M | 404.6M | 99.2M | 60.3M |
| EBIT | -284.4M | -271.5M | 1.07B | 695.3M | 1.12B | 970.4M | 369.9M | 480.6M | 410M | -259.3M | 9.7M |
| Net Interest Income | -172.4M | -169.8M | -218.8M | -284.8M | -265.8M | -217.4M | -307.6M | -440M | -523.8M | -200.9M | -80.3M |
| Interest Income | 10.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 182.9M | 169.8M | 218.8M | 284.8M | 265.8M | 217.4M | 307.6M | 440M | 523.8M | 200.9M | 80.3M |
| Other Income/Expense | -192.9M | -195.1M | -230.9M | -285.9M | -279.1M | -219.2M | -644.5M | -511.2M | -527.3M | -249.8M | -80.5M |
| Pretax Income | -471.5M | -441.3M | 853.9M | 410.5M | 851.1M | 753M | 62.3M | 40.6M | -113.8M | -460.2M | -70.6M |
| Pretax Margin % | -7.2% | -6.74% | 12.59% | 5.89% | 11.33% | 10.19% | 0.97% | 0.67% | -1.94% | -36.89% | -10.21% |
| Income Tax | 79.9M | 88.9M | 142.4M | 89.4M | 164.6M | 180.4M | -54.3M | 2.8M | -26.9M | -314.9M | 10.1M |
| Effective Tax Rate % | -16.95% | -20.15% | 16.68% | 21.78% | 19.34% | 23.96% | -87.16% | 6.9% | 23.64% | 68.43% | -14.31% |
| Net Income | -551.4M | -530.2M | 711.5M | 321.1M | 686.5M | 572.6M | 116.6M | 37.8M | -86.9M | -112.7M | -42.4M |
| Net Margin % | -8.42% | -8.09% | 10.49% | 4.61% | 9.14% | 7.75% | 1.82% | 0.63% | -1.48% | -9.03% | -6.13% |
| Net Income Growth % | -177.05% | -174.52% | 121.58% | -53.23% | 19.89% | 391.08% | 208.47% | 143.5% | 22.89% | -165.8% | - |
| Net Income (Continuing) | -551.4M | -530.2M | 711.5M | 321.1M | 686.5M | 572.6M | 116.6M | 37.8M | -86.9M | -145.3M | -80.7M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -135.7M |
| EPS (Diluted) | -0.81 | -0.78 | 1.04 | 0.47 | 1.01 | 0.85 | 0.09 | -0.84 | -0.72 | -0.84 | -0.09 |
| EPS Growth % | -176.67% | -175% | 121.28% | -53.47% | 18.82% | 844.44% | 110.71% | -16.67% | 14.29% | -873.35% | - |
| EPS (Basic) | - | -0.78 | 1.05 | 0.48 | 1.02 | 0.86 | 0.09 | -0.84 | -0.72 | -0.84 | -0.09 |
| Diluted Shares Outstanding | 679.3M | 679.3M | 681.9M | 678.4M | 679.4M | 599.6M | 583.4M | 401.2M | 496.5M | 496.5M | 491.3M |
| Basic Shares Outstanding | 678M | 678M | 680.3M | 675.6M | 650.9M | 590.5M | 576.3M | 401.2M | 496.5M | 496.5M | 491.3M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | 82.8% | - | - | - |
Persistent revenue contraction
As indicated by the most recent quarterly data, Avantor's revenue growth has remained stagnant or negative, with the company reporting a 0.0% growth rate in 2026Q1 following a consistent pattern of year-over-year declines that suggest ongoing challenges in stabilizing its core bioprocessing and laboratory supply volumes.
The lack of top-line expansion appears to reflect a prolonged period of inventory destocking across the biopharma customer base. Investors should monitor whether this stagnation represents a structural shift in demand or merely a cyclical trough in the post-pandemic environment.
Based on reported financial statements, Avantor's gross margins have drifted downward from 34.1% in 2024Q2 to 31.7% in 2026Q1, highlighting the difficulty of maintaining pricing power while navigating a mix shift toward lower-margin distributed products rather than proprietary high-purity chemical solutions.
The erosion of gross margin suggests that the company's distribution-heavy model is highly sensitive to competitive pricing pressures. This trend warrants further investigation into whether the company can successfully pivot its portfolio toward higher-value, single-use assemblies to restore historical profitability levels.
According to the income statement history, operating margins have struggled to scale, fluctuating significantly and even turning negative in 2025Q3, which implies that the company's fixed cost base remains poorly aligned with current revenue levels during periods of volume volatility.
The inability to consistently expand operating income relative to gross profit suggests that SG&A expenses are not sufficiently flexible to offset revenue declines. This lack of operating leverage may indicate that the company is carrying excess overhead from its previous acquisition-led growth phase.
As reported in recent filings, the significant disparity between GAAP net income and operational performance, exemplified by the massive $711.8M net loss in 2025Q3, suggests that non-recurring charges and impairment events are heavily distorting the company's true earnings power for institutional investors.
The presence of large, non-cash charges indicates that previous capital allocation decisions may require downward valuation adjustments. Analysts should focus on adjusted metrics to determine if the underlying business remains cash-generative despite the headline volatility in reported net income.
Based on the provided data, the company's reliance on a distribution-heavy revenue stream creates a structural risk, as evidenced by the 2025Q3 operating margin collapse, which suggests that the business lacks the defensive moat required to protect profitability during industry-wide demand downturns.
Short-sellers may focus on the potential for further margin compression if the company fails to increase its proprietary product mix. The current financial profile appears to lack the resilience of its more specialized peers, making it particularly susceptible to further inventory corrections.
Quick answers to the most common questions about buying AVTR stock.
For fiscal year 2025, Avantor, Inc. (AVTR) reported total revenue of $6.55B. This represents a 847.8% increase compared to $691.3M in 2016.
Avantor, Inc. (AVTR) reported a net loss of $530.2M for the fiscal year ending 2025.
Avantor, Inc. (AVTR) reported an operating income of $-246.2M, resulting in an operating profit margin of -3.8%. This margin reflects the operational efficiency of the business before interest and taxes.
Avantor, Inc. (AVTR) generated $2.14B in gross profit for the year, representing a gross profit margin of 32.7%. This demonstrates the company's core pricing power and production efficiency.